Sonnet BioTherapeutics

$2.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.47%) Today

-$0.03 (-1.42%) As of 11:10 PM UTC after-hours

Why Robinhood?

You can buy or sell SONN and other stocks, options, and ETFs commission-free!

About SONN

Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues.

CEO

Pankaj Mohan

Employees

Headquarters

Princeton, New Jersey

Founded

2011

Market Cap

38.70M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

626.30K

High Today

$2.14

Low Today

$2.02

Open Price

$2.12

Volume

412.70K

52 Week High

$16.20

52 Week Low

$1.81

SONN Earnings

-$4.73

-$3.15

-$1.58

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected May 12, Pre-Market